Consent at Last

A working group including members of the Lacks family approves the first projects to use the HeLa genome.

By | September 18, 2013

Henrietta Lacks in 1945WIKIMEDIA, IMAGE COURTESY OF THE LACKS FAMILY Four biomedical research groups have been  approved by a National Institutes of Health (NIH) committee to access the HeLa genome under an agreement enacted with the help of the Lacks family in August. The cell line, established in 1951 from cervical cancer patient Henrietta Lacks, was the subject of controversy earlier this year when researchers published the HeLa genome without the consent of Lacks’s surviving family.

The HeLa Genome Data Access Working Group, which includes representatives of the Lacks family and from the NIH, was formed to ensure the HeLa genome would be used in projects consistent with the family’s wishes to preserve their privacy, as well as the cell line’s history of public good. Of six applicants to date, four projects were approved and two are pending, according to NIH.

Last month, when the HeLa genome agreement was reached, science journalist Rebecca Skloot told The Scientist: “What’s important is that this is a very big statement from the NIH and from the scientific community saying, ‘It matters to know what the subjects want and to tell them what’s going on.”’ In that way, yes, this is setting an important precedent.”

(Hat tip to Nature News Blog.)

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech